Key Highlights

• Cognyte reported Q1 fiscal 2027 non-GAAP EPS of $0.03, falling 67% short of the $0.09 analyst consensus and declining 57% year-over-year, as accelerated subscription adoption weighed on near-term profitability.
• Revenue of $105.5 million grew 10.4% year-over-year and edged past estimates, while adjusted EBITDA of $13.6 million grew 31.5% year-over-year, offering a more constructive picture of underlying operational progress.
• Management reaffirmed full-year fiscal 2027 guidance of approximately $448 million in revenue and $0.47 non-GAAP EPS, signalling confidence in the Business trajectory despite the quarterly profitability shortfall.

An Earnings-Driven Repricing

Shares of Cognyte Software Ltd. (Nasdaq: CGNT) closed at $9.23 on June 3, 2026, down 20.57% on Volume of 3.03 million shares at approximately five times the normal daily pace. Cognyte is an Israel-based software-led technology company and global leader in investigative analytics, spun out of Verint Systems and listed on NASDAQ in February 2021. With approximately 1,623 employees, trailing revenues of approximately $400 million, and roughly 90% of revenues derived from software under CEO Elad Sharon, Cognyte serves national, regional, and local government agencies as well as commercial security enterprises through network, threat, decision, and operational intelligence analytics.

The confirmed catalyst was Q1 fiscal 2027 results: non-GAAP EPS of $0.03, a 67% shortfall versus the $0.09 analyst consensus and a 57% year-over-year decline. Elevated, earnings-driven volume confirms a genuine repricing rather than a momentum event.

The Mechanics of the Miss: Subscription Acceleration

The earnings shortfall carries an important contextual explanation. Management attributed the profitability decline to accelerated adoption of subscription-based licensing, which pulls Recurring Revenue forward into future periods while compressing near-term recognised earnings relative to perpetual licence sales. In software companies transitioning from licence to subscription models, near-term EPS takes a hit as revenue recognition shifts even as the long-term revenue quality improves.

The supporting metrics reflect this dynamic. Adjusted EBITDA of $13.6 million grew 31.5% year-over-year, suggesting that operational efficiency is improving even as reported earnings lag. Approximately 50% of revenues are now recurring, and nearly 90% are derived from software, indicating progress toward the durable, high-Margin subscription structure that commands premium software valuations.

Revenue and Guidance Provide a Constructive Counterpoint

Revenue of $105.5 million grew 10.4% year-over-year and edged past analyst estimates, indicating that Demand for Cognyte's AI-powered investigative analytics platform remains robust, with management citing growing US momentum as a notable demand driver. The reaffirmation of full-year fiscal 2027 guidance at approximately $448 million in revenue and $0.47 in non-GAAP EPS signals that management views the Q1 profitability shortfall as a timing issue rather than a structural deterioration. Whether the market accepts that framing depends on EPS recovery in subsequent quarters.

Valuation and Risk Considerations

CGNT reports a trailing EPS of -$0.04 and trades without a conventional P/E ratio. Its Market Capitalisation of $680.31 million against approximately $400 million in trailing revenue implies a price-to-sales ratio near 1.7x, reasonable for a software business in subscription transition. The 52-week range of $6.29 to $12.31 provides context for the scale of the session's decline. Key risks include the execution timeline for subscription transition, lumpiness in government contract renewals, and sensitivity of the valuation to quarterly EPS variability during the transition.

Conclusion

Cognyte's 20.57% session decline is an earnings-driven repricing grounded in a specific, disclosed profitability shortfall rather than a demand or structural problem. The subscription transition explains the near-term earnings compression, while EBITDA growth, revenue expansion, and reaffirmed full-year guidance provide a constructive longer-term backdrop. Recovery will depend on the pace at which subscription adoption stabilises and quarterly EPS tracks toward the $0.47 full-year guidance.